Volume 27, Number 2—February 2021
Research
Universal Admission Screening for SARS-CoV-2 Infections among Hospitalized Patients, Switzerland, 2020
Thomas Scheier, Adrian Schibli, Geri Eich, Christian Rüegg, Frank Kube, Adrian Schmid, Urs Karrer, Aline Wolfensberger, Hugo Sax, and Peter W. Schreiber
Table 2
Characteristics of hospitalized patients in study on severe acute respiratory syndrome coronavirus 2, canton of Zurich, Switzerland, 2020*
| Characteristic | Total | PCR results for severe acute respiratory syndrome coronavirus 2 |
|
|---|---|---|---|
| Negative | Positive | ||
| Total |
2,807 |
2,739 (97.6) |
68 (2.4) |
| Hospital | |||
| GZO Wetzikon | 283 | 277 (97.9) | 6 (2.1) |
| Cantonal Hospital Winterthur | 409 | 403 (98.5) | 6 (1.5) |
| City Hospital Triemli | 583 | 567 (97.3) | 16 (2.7) |
| University Hospital Zurich |
1,532 |
1,492 (97.4) |
40 (2.6) |
| Median age, y (IQR) |
60 (39–74) |
60 (39–74) |
54.5 (44.5–69) |
| Sex | |||
| M | 1,368 | 1,330 (97.2) | 38 (2.8) |
| F |
1,439 |
1,409 (97.9) |
30 (2.1) |
| Symptoms | |||
| Any symptom of coronavirus disease | 529 | 469 (88.7) | 60 (11.3) |
| Fever/feeling feverish | 205 | 167 (81.5) | 38 (18.5) |
| Cough | 192 | 152 (79.2) | 40 (20.8) |
| Dyspnea | 282 | 255 (90.4) | 27 (9.6) |
| Sore throat | 30 | 22 (73.3) | 8 (26.7) |
| Myalgia | 27 | 14 (51.9) | 13 (48.1) |
*Values are no. (%) except as indicated.
Page created: November 17, 2020
Page updated: January 23, 2021
Page reviewed: January 23, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.